Milestone Pharmaceuticals Inc.MISTNASDAQ
Loading
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Gross Profit Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +54.03% | +85.80% | +32.16% | +0.32% | +0.29% |
| Weighted Average Shares Diluted Growth | +54.03% | +85.80% | +32.16% | +0.32% | +0.29% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +0.00% | -37.91% | +1.74% | -16.30% | -26.37% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | -5.06% | +0.36% | -35.54% | -46.86% | +6.10% |
| Book Value per Share Growth | -45.31% | -57.81% | +0.00% | +0.00% | -14.87% |
| Debt Growth | +5.86% | +5.84% | +5.87% | +5.90% | +5.91% |
| R&D Expense Growth | -41.04% | -26.30% | +36.80% | +30.34% | +1.26% |
| SG&A Expenses Growth | -34.56% | -0.85% | +127.37% | +29.43% | +39.11% |